wp-plugin-hostgator
domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init
action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home4/scienrds/scienceandnerds/wp-includes/functions.php on line 6114ol-scrapes
domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init
action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home4/scienrds/scienceandnerds/wp-includes/functions.php on line 6114Source: https:\/\/www.theverge.com\/2022\/1\/20\/22893444\/neuralink-human-clinical-trials-musk<\/a> Elon Musk\u2019s brain-machine interface company Neuralink has a new job posting<\/a> for a clinical trial director, a position that could help the company move towards its stated goal of testing its brain implant in actual people. <\/p>\n Since launching publicly in 2017<\/a>, Neuralink has demoed its brain implant in pigs<\/a> and monkeys<\/a> but has yet to announce a start to the long-promised trials in humans. The company\u2019s implant is a coin-like device with electrodes studded on thin, flexible wires. The wires are its main innovation over older brain-machine interfaces, which use stiffer needles that can damage cells in the brain. <\/p>\n The company needs to do trials in humans before it can get Food and Drug Administration (FDA) approval for general medical use \u2014 key for Musk\u2019s stated plan<\/a> to use the devices to solve a number of neurological problems, from memory loss to addiction. <\/p>\n The clinical trial director job posting, first reported by Bloomberg<\/em><\/a>, says that the person in the role will be \u201cworking with Neuralink\u2019s first Clinical Trial participants,\u201d though it\u2019s not clear if the company has started recruiting or working with participants at this point. Musk said<\/a> in December that the company aims to have the device implanted in the first human subjects in 2022. That\u2019s not the first prediction he\u2019s made, though \u2014 Musk previously said<\/a> he hoped to start trials in 2020. <\/p>\n The clinical trial process would start with a feasibility study to get a first look at how the device works in a small number of people. Then, because the device is high-risk and hasn\u2019t been previously used in people, the company would need FDA approval to launch a larger-scale trial. According to the job posting, the clinical trial director would be responsible for interactions with regulators like the FDA.<\/p>\n The person who takes the clinical trials director position will enter a scientific environment that ex-employees told Stat News<\/em><\/a> in 2020 was chaotic and was characterized by pressure to deliver scientific progress on unreasonably short timelines. They\u2019d have to handle Musk\u2019s consistent promises of timelines that haven\u2019t previously panned out and his publicly-stated ambitions that still go beyond what scientists say are reasonable expectations<\/a> for brain-machine interfaces. None of that is in the job description. <\/p>\n<\/div>\n
\n
<\/br><\/code><\/p>\n